Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04542330Phase 3Completed

Using BCG to Protect Senior Citizens During the COVID-19 Pandemic

Role: collaborator

NCT02183558Not ApplicableCompleted

Screening for GDM in Women With PCOS and Controls

Role: collaborator

NCT04531852Completed

Community-based Complex Intervention to Prevent Loss of Physical Function and Disability in Home-dwelling Older Adults

Role: collaborator

All 3 trials loaded